DNA methylation in endometrial cancer.
Endometrial cancer is the most commonly diagnosed gynecological cancer, and it has been shown to be a complex disease driven by abnormal genetic, and epigenetic alterations, as well as environmental factors. Epigenetic changes resulting in aberrant gene expression are dynamic and modifiable features of many cancer types. A significant epigenetic change is aberrant DNA methylation. In this review, we review evidence on the role of aberrant DNA methylation, examining changes in relation to endometrial carcinogenesis, and report on recent advances in the understanding of the contribution of aberrant DNA methylation to endometrial cancer with the emphasis on the role of dietary/ lifestyle and environmental factors, as well as opportunities and challenges of DNA methylation in endometrial cancer management and prevention.
Tao
Meng Hua
MH
Department of Social and Preventive Medicine; School of Public Health and Health Professions; University at Buffalo, NY, USA. mtao@buffalo.edu
Freudenheim
Jo L
JL
D000818:Animals; D002277:Carcinoma / Q000235:genetics* / Q000473:pathology; D019175:DNA Methylation / Q000502:physiology*; D016889:Endometrial Neoplasms / Q000235:genetics* / Q000473:pathology; D004777:Environment; D005260:Female; D052138:Genes, Neoplasm / Q000235:genetics; D006801:Humans; D011401:Promoter Regions, Genetic / Q000235:genetics